Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 66.00
0.00 (0.00%)
Jun 24, 2026, 3:30 PM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 5.05 billion as of June 24, 2026. Its market cap has decreased by -45.98% in one year.
Market Cap
5.05B
Enterprise Value
3.93B
Revenue
593.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.00
Market Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 5.05B, an increase of 974.69%. That is a compound annual growth rate of 17.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 5.05B | -30.62% |
| Dec 30, 2025 | 7.28B | -58.55% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kidswell Bio | 6.80B |
| Soiken Holdings | 6.43B |
| Carna Biosciences | 6.35B |
| BrightPath Biotherapeutics | 6.25B |
| CellSource | 6.13B |
| Noile-Immune Biotech | 5.21B |
| Kohjin Bio | 4.99B |
| PRISM BioLab Co.,LTD | 4.88B |